In my last post here, I reported that the Medicare Payment Advisory Commission (MedPAC) believes Medicare ACOs and “medical homes” are unlikely to qualify as “alternative payment models” under MACRA (the Medicare Access and CHIP Reauthorization Act).
In this article I review the evidence supporting MedPAC’s pessimistic assessment of “patient-centered medical homes” (PCMHs). I will review evidence that PCMHs are not cutting Medicare costs but are probably inflicting financial and emotional stress on many PCMH clinics. In a future post I will review the evidence on Medicare ACOs. Down the road I hope to comment on bundled payments. PCMHs, ACOs, and bundled payments are the three templates available to CMS to fashion APMs.
“Medical homes” may be raising Medicare’s costs
Within five years after the PCMH fad appeared, CMS had begun three demonstrations to test the ability of PCMHs to lower Medicare costs while simultaneously improving quality. The first of these demos, the FQHC Advanced Primary Care Practice Demonstration , ended in October 2014. The other two, the Comprehensive Primary Care (CPC) Initiative and the Multi-payer Advanced Primary Care Practice (MAPCP) Demonstration, will end this year. [1]
CMS has released evaluations of the first two years of the FQHC and CPC demos , and an evaluation of the first year of the MAPCP demo . CMS has delayed the second-year evaluation of the MAPCP demo. [2]
The findings presented in these evaluations are not good news for PCMH supporters. In a recent report , the Kaiser Family Foundation (KFF) offered this summary of the results of the three PCMH demos: “Among the office-based multi-payer models (MAPCP and CPC) and the FQHC/APCP model, little to no savings have been generated after accounting for the outgoing Medicare expenditures in care management fees” (see Table 2 of the report).
As promised last week, I’ve read and taken detailed notes on the
Few appreciate the threat of antibiotic resistance to human medicine more than readers of this blog. You know antibiotics as lifesaving “miracle” drugs that treat sepsis, save victims of burns and trauma, and are crucial to survival of patients receiving transplants and cancer treatment.
Opinions about the U.S. health system vary widely based largely on our individual experiences as users from time to time. And most Americans don’t think of it as a system at all. Rather, it’s a collection of doctors, hospitals, insurers, drug and device manufacturers and others that operate in a complicated, disconnected, expensive industry that’s increasingly difficult to navigate and afford.
Hillary Clinton is now the presumptive Democratic nominee and the odds-on favorite to be our next president. 
